India · Delayed Price · Currency is INR Suven Life Sciences Statistics
Total Valuation
NSE:SUVEN has a market cap or net worth of INR 89.86 billion. The enterprise value is 84.85 billion.
| Market Cap | 89.86B |
| Enterprise Value | 84.85B |
Important Dates
The next estimated earnings date is Tuesday, August 11, 2026.
| Earnings Date | Aug 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 263.72M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +4.47% |
| Shares Change (QoQ) | +0.77% |
| Owned by Insiders (%) | 1.88% |
| Owned by Institutions (%) | 2.94% |
| Float | 75.00M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1,263.06 |
| PB Ratio | 15.19 |
| P/TBV Ratio | 15.20 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 17.69, with a Debt / Equity ratio of 0.03.
| Current Ratio | 17.69 |
| Quick Ratio | 16.94 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.05 |
| Interest Coverage | -1,838.51 |
Financial Efficiency
Return on equity (ROE) is -78.80% and return on invested capital (ROIC) is -527.21%.
| Return on Equity (ROE) | -78.80% |
| Return on Assets (ROA) | -47.75% |
| Return on Invested Capital (ROIC) | -527.21% |
| Return on Capital Employed (ROCE) | -48.90% |
| Weighted Average Cost of Capital (WACC) | 8.83% |
| Revenue Per Employee | 515,558 |
| Profits Per Employee | -20.02M |
| Employee Count | 138 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +16.99% in the last 52 weeks. The beta is 0.84, so NSE:SUVEN's price volatility has been lower than the market average.
| Beta (5Y) | 0.84 |
| 52-Week Price Change | +16.99% |
| 50-Day Moving Average | 280.09 |
| 200-Day Moving Average | 198.58 |
| Relative Strength Index (RSI) | 61.52 |
| Average Volume (20 Days) | 2,046,019 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:SUVEN had revenue of INR 71.15 million and -2.76 billion in losses. Loss per share was -12.13.
| Revenue | 71.15M |
| Gross Profit | 71.15M |
| Operating Income | -2.90B |
| Pretax Income | -2.76B |
| Net Income | -2.76B |
| EBITDA | -2.85B |
| EBIT | -2.90B |
| Loss Per Share | -12.13 |
Balance Sheet
The company has 5.22 billion in cash and 166.94 million in debt, with a net cash position of 5.05 billion.
| Cash & Cash Equivalents | 5.22B |
| Total Debt | 166.94M |
| Net Cash | 5.05B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 5.91B |
| Book Value Per Share | 26.20 |
| Working Capital | 5.16B |
Cash Flow
In the last 12 months, operating cash flow was -3.02 billion and capital expenditures -50.83 million, giving a free cash flow of -3.07 billion.
| Operating Cash Flow | -3.02B |
| Capital Expenditures | -50.83M |
| Depreciation & Amortization | 56.14M |
| Net Borrowing | n/a |
| Free Cash Flow | -3.07B |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -4,077.70% |
| Pretax Margin | -3,884.13% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NSE:SUVEN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.47% |
| Shareholder Yield | -4.47% |
| Earnings Yield | -3.08% |
| FCF Yield | -3.41% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |